Conclusion
Interferon shows promising results when used for the treatment of polycythemia vera with a durable hematologic and molecular response and has an acceptable side effects profile. However, large randomized clinical trials are needed to confirm these findings and to explore the dose and combination of interferon with other drugs..
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaAbbas Weighs Options in Patient With JAK2-Mutated Polycythemia Vera
Anyone with both GCA and also Polycythemia Vera ? Ruxolitinib Provides Better Efficacy Than Best Available Therapy in Polycythemia VeraRopeginterferon Alfa-2b listed as Preferred Treatment in Polycythemia Vera
